CUMULATIVE INDEX 1992 Volume 10 January NEW DEVELOPMENTS IN DERMATOPATHOLOGY, pages 1-273 April VULVAR DISEASES, pages 275-472 July OCULOCUTANEOUS DISEASES I, pages 473-651 October OCULOCUTANEOUS DISEASES II, pages 653-807 Note: Page numbers for complete issues and articles are in boldface type. Abetalipoproteinemia, oculocutaneous features of, 735 Adenomas, aggressive digital papillary, Acanthosis nigricans, in diabetes, 718 dermatopathology of, 120, 123 Acetowhitening, of HPV infection, 258 papillary eccrine, dermatopathology of, 118-120 Acid burns, of eyes, 786-787 Adenoviral infections, oculocutaneous features of, 758 Acids, for HPV infection, 260 Adnexal neoplasms, dermatopathology of, 117-160 Acitretin, and oculocutaneous diseases, 525-526 adenoid cystic carcinoma, 123-126 Acquired benign vascular lesions, dermatopathology aggressive digital papillary adenomas and, of, 97-115 adenocarcinoma, 120, 123 angioendotheliomatosis, 107-108 Bowen's disease, 131-136 angiokeratomas, 98-99 eccrine epitheliomas, 145-146 angiolymphoid hyjjerplasia with eosinophilia, 108- intraepidermal epitheliomas, 136-138 109 Merkel's cell carcinoma, 126-129 angioma serpiginosum, 97-98 microcystic adnexal carcinoma, 138, 141, 143-144 arteriovenous hemangiomas, 98 papillary eccrine adenomas, 118-120 endovascular papillary angioendotheliomas, 111- sclerosing sweat duct carcinoma, 144-145 112 solitary subcutaneous trichoepitheliomas, 151-158 epithelioid hemangioendotheliomas, 109 syringoid eccrine carcinoma, 149, 151 glomeruloid hemangiomas, 105-106 Adrenal diseases, oculocutaneous features of, 723 intravascular papillary endothelial hyperplasia, 107 Adriamycin, photosensitizing effects of, ocular, 491 microvenular hemangiomas, 100, 103 Aggressive digital papillary adenocarcinoma, multinucleate cell angiohistiocytomas, 106-107 dermatopathology of, 120, 123 pyogenic granulomas, 100 Aggressive digital papillary adenomas, spindle cell hemangioendotheliomas, 109-111 dermatopathology of, 120, 123 targetoid hemosiderotic hemangiomas, 103-105 AIDS, leprosy in, 90 tufted angiomas, 100 mechanisms of visual loss in, 781-782 verrucous hemangiomas, 99 oculocutaneous features of, 777-783 Acquired immunodeficiency syndrome. See AIDS. bacterial infections of rehna and choroid, 780 Acquired tufted angiomas, dermatopathology of, 100 conjunctival lesions, 778 Acral erythema, chemotherapy-induced, 23 microangiopathy, 779 Acrochordons, vulvar, 371-372 neuro-ophthalmologic features, 778-779 AcrodermatiHs chronica atrophicans, in Lyme disease, opportunistic retinal infections, 779 765 orbital lesions, 778 Acrodermatitis enteropathica, vulvar, 453 periorbital lesions, 778 Acyclovir, for herpes genitalis, 464-465 Pneumocystis carinii choroiditis, 781 with HIV infection, 465 toxoplasmosis, 780-781 for herpehc ocular infections, 748 viral retinitis, 779-780 for vulvar herpes genitalis, 419—420 risk of, sexually transmitted diseases and, 460 for vulvodynia, in herpes simplex, 428 vulvar chancroid in, 393 Addison's disease, oculocutaneous features of, 723 vulvar syphilis in, 392 Adenocarcinoma, aggressive digital papillary, Akinesia, of orbicularis oculi muscle, 703-705 dermatopathology of, 120, 123 Albinism, oculocutaneous features of, 610, 612-613 Adenoid cystic carcinoma, dermatopathology of, 123- Alcohol, injections of, and vulvodynia, 430 126 Alkaline bums, of eyes, 785-786 Adenoma sebaceum, in tuberous sclerosis, 630-631 Alkaptonuria, oculocutaneous features of, 726-727 807 808 CUMULATIVE INDEX 1992 Allergic contact dermatitis, and upper eyelid Antiviral medications, for herpetic ocular infections, dermatosis syndrome, 550-551 748 Allopurinol, photosensitizing effects of, ocular, 491 Aphthosis, vulvar, 447 Allylamines, dermatologic uses of, 803 Aplasia cutis congenita, oculocutaneous features of, Alpha,-antitrypsin deficiency, panniculitis in, 44 589 Alprazolam, dermatologic uses of, 642 Argon laser therapy, for oculocutaneous diseases, 691- Amblyopia, periorbital hemangiomas and, 655-656 692 Amebiasis, vulvar, 446 Arterial hypertension, steroids and, 509 American trypanosomiasis, oculocutaneous features of, Arteriovenous hemangiomas, dermatopathology of, 98 751 Arthritis, in Lyme disease, 766 Amiodarone, and hyperpigmentahon, 19-21 in Reiter's syndrome, 715 Amorolfine, dermatologic uses of, 804 psoriasis and, 543 Amoxicillin, for Lyme disease, 772, 773 Atheromatous embolization, and hemorrhagic Amphotericin B, dermatologic uses of, 799-800 panniculitis, 53 Amyloidosis, oculocutaneous features of, 736-737 Atkinson block, of eyes and orbits, 704 Androgens, increased secreHon of, vulvar features of, Atopic dermatitis, and upper eyelid dermatosis 452-453 syndrome, 552 Anesthesia, regional. See Regional anesthesia. oculocutaneous features of, 536-539 Anesthetics, for vulvar diseases, 279 vulvar, and pruritus vulvae, 301 Angioendotheliomas, endovascular papillary, Autoimmune disease, and vulvar lichen sclerosus, 310 dermatopathology of, 111-112 Azathioprine, for drug-induced ocular pemphigoid, 568 Angioendotheliomatosis, dermatopathology of, 107- Azoles, for vulvovaginitis, in candidiasis, 3^-353 108 Angiofibromas, facial, in tuberous sclerosis, 630-631 Angiohistiocytomas, multinucleate cell, dermatopathology of, 106-107 Bacillary angiomatosis, in HIV infec’ion, 62-64 Angioid streaks, in pseudoxanthoma elasticum, 592 Bacterial infections, of choroid and retina, in AIDS, 780 Angiokeratoma corporis diffusum, oculocutaneous of skin, in HIV infection, 61-64 features of, 735-736 Bacterial vaginosis, and vulvovaginitis, 344-347 Angiokeratomas, dermatopathology of, 98-99 Balanitis, in Reiter's syndrome, 714 vulvar, 376 Balloon cell malignant melanoma, dermatopathology Angiolymphoid hyperplasia, with eosinophilia, of, 175, 178-180 dermatopathology of, 108-109 Basal cell carcinoma, periocular, 676-679 Angioma serpiginosum, dermatopathology of, 97-98 vulvar, 372-374 Angiomas, acquired tufted, dermatopathology of, 100 Basal cell nevus syndrome, oculocutaneous features of, retinal, in tuberous sclerosis, 633 586-587 Angiomatosis, bacillary, in HIV infection, 62-64 Bassen-Kornzweig syndrome, oculocutaneous features encephalofacial, oculocutaneous features of, 633-637 of, 735 Angiomyomas, aggressive, vulvar, 383-384 B-cell lymphomas, in HIV infection, 68 Anisometropia, periorbital hemangiomas and, 655 Behcet's disease, oculocutaneous features of, 712-714 Anogenital warts, dermatopathology of, 253-254 vulvar, 447-448 treatment of, 263 Benign fibrous and fibrohistiocyhc tumors, Anterior uveitis, in sarcoidosis, 710 dermatopathology of, 203-217 Antianxiety medications, dermatologic uses of, 641-642 dermatofibromas extending into subcutaneous tis¬ Anticompulsive medications, dermatologic uses of, 644 sue, 205-208 Antidepressant medications, dermatologic uses of, dermatofibromas with atypical cells, 203-205 642-643 dermatomyofibromas, 212-215 tricyclic, for desquamative vulvitis, 335 epithelioid cell histiocytomas, 211-212 for vulvodynia, 431 palisading cutaneous fibrous histiocytomas, 208 Antifungal medications, dermatologic uses of, 799-805 pleomorphic fibromas, 208-209 amorolfine, 804 sclerotic fibromas, 209-210 amphotericin B, 799-800 Benign vulvar tumors, 371-385 cilofungin, 804 of epithelial origin, 371-376 fluconazole, 802-803 acrochordons, 371-372 itraconazole, 802 basal cell carcinoma, 372-374 ketoconazole, 800-802 endometriosis, 374, 376 piritetrate, 804 hidradenomas, 374 terbinafine, 803 keratoacanthomas, 372 Antimalarial medications, and oculocutaneous seborrheic keratosis, 371 diseases, 513-519 syringomas, 374 clinical efficacy of, 514-515 of mesenchymal origin, 376, 378-382 historical aspects of, 513 aggressive angiomyomas, 383-384 mechanism of action of, 514 angiokeratomas, 376 pharmacology of, 513-514 dermatofibromas, 381 side effects of, 515-518 fibromas, 380-381 Antineutrophil cytoplasmic antibodies, disorders fibrous histiocytomas, 381 associated with, 12-15 granular cell tumors, 383 Antiphospholipid syndrome, dermatopathology of, 10- hemangiomas, 376 12 Kaposi's sarcoma, 378, 380 Antipsychotic medications, dermatologic uses of, 643 leiomyomas, 381, 383 CUMULATIVE INDEX 1992 809 lipomas, 383 galactosemia, 732-733 lymphangiomas, 378 glycogenoses, 730-732 neurilemmomas, 383 mucopolysaccharidosis, 732 neurofibromas, 383 Carbon dioxide laser therapy, and vulvodynia, 429-430 nodular fasciitis, 381 for HPV infection, 260-261 pyogenic granulomas, 378 for oculocutaneous diseases, 688-691 rhabdomyomas, 383 for vulvar condylomata acuminata, 406 sclerosing lipogranulomas, 381 Carcinoma, adnexal, dermatopathology of. See Adnexal Benzodiazepines, dermatologic uses of, 642 neoplasms. Beta-carotene, and oculocutaneous diseases, 524-525 basal cell, vulvar, 372-374 Biopsy, of desquamahve vulvitis, in chronic bullous periocular. See Periocular tumors. disease of childhood, 331 vulvar, HPV infecHon and, 410 in cicatricial pemphigoid, 330 squamous cell, 291-294 in contact dermatitis, 334 and desquamative vulvitis, 334-335 in erythema multiforme major, 332-333 verrucous, 294-295 in lichen planus, 327 Cardiac abnormalities, in Lyme disease, 767 in lichen sclerosus, 328 Cataracts, atopic dermatitis and, 537 in lupus erythematosus, 333 chondrodysplasia punctata and, 603 in pemphigus vulgaris and pemphigus vegetans, extracapsular extraction of, lasers in, 698 332 steroids and, 506-507 in squamous cell carcinoma in situ, 335 Cavernous hemangiomas, carbon dioxide laser therapy in Stevens-Johnson syndrome, 332-333 for, 690 in toxic epidermal necrolysis, 332-333 pulsed dye laser therapy for, 693 of vulvar diseases, 278 Ceftriaxone, for gonorrhea, 461 Biotinidase deficiency, oculocutaneous features of, 727 for Lyme disease, 772, 773 Blastomycosis, ketoconazole for, 801 Cellular schwannomas, dermatopathology of, 224-226 Blepharitis, and upper eyelid dermatosis syndrome, Cellulitis, oculocutaneous features of, 753-755 552 Central nervous system, glial cell lesions of, in oculocutaneous features of, 539-542 neurofibromatosis, 627-629 staphylococcal, 741-742, 744 Central nervous system toxicity, regional anesthesia Blepharochalasis, oculocutaneous features of, 796-798 and, 706-707 Blepharoconjunctivitis, retinoids and, 527-528 Cephalosporin, and pemphigus-like syndrome, 28-30 Blepharoplasty, carbon dioxide laser in, 690-691 Cerebrospinal fluid, examination of, for neurosyphilis, Bloch-Sulzberger syndrome, oculocutaneous features 463 of, 617 in Lyme disease, 772 Bloom's syndrome, oculocutaneous features of, 583- Cervical warts, dermatopathology of, 254 584 CerviciHs, in Reiter's syndrome, 714-715 Bourneville's disease, oculocutaneous features of, 615- Chagas' disease, oculocutaneous features of, 751 616, 630-632 Chalazia, staphylococcal, 742 Bowen's disease, dermatopathology of, 131-136 Chancroid, diagnosis and treatment of, 462 vulvar, 409 vulvar, 393-394 Bowenoid papulosis, dermatopathology of, 255 Chemical bums, of eyes. See Eyes. treatment of, 263 Chemotherapy, drug reactions to, 21-27 vulvar, 409 for leprosy. See Leprosy. Bullous diseases, and pruritus vulvae, 304-305 Chlamydial infections, diagnosis and treatment of, chronic, of childhood, and desquamative vulvitis, 461-462 331 oculocutaneous features of, 757-758 Burns, of eyes. See Eyes. Chlorambucil, for Behcet's disease, 714 Buschke-Lowenstein tumors, dermatopathology of, 258 Chloroquine, photosensitizing effects of, ocular, 492 Buspirone, dermatologic uses of, 642 Chlorpromazine, photosensitizing effects of, ocular, Busulfan, and cutaneous eruptions, 25 491 Chondrodysplasia punctata, oculocutaneous features of, 602-604 Choroid, bacterial infections of, in AIDS, 780 Cafe au lait spots, in neurofibromatosis, 624 Choroidal lesions, in neurofibromatosis, 625 Calcification, intracranial, in Sturge-Weber syndrome, in Sturge-Weber syndrome, 636 634-635 Choroidal melanomas, 664-667 Calcifying panniculitis, in renal disease, diagnosis of, 665 dermatopathology of, 51 differenhal diagnosis of, 665-666 Canaliculitis, oculocutaneous features of, 752-753 oculocutaneous features of, 664-665 Candida albicans, in ocular infections, 746 pathology of, 666 Candida infections, and vulvodynia, 427 photoradiation for, lasers in, 698 Candidiasis, and vulvar vestibulitis syndrome, 440 prognosis for, 666 treatment of, 442 treatment of, 666-667 and vulvovaginitis, 347-353 Choroidal nevi, vs. choroidal melanomas, 665-666 Capillary hemangiomas, carbon dioxide laser therapy Cicatricial pemphigoid, and desquamative vulvitis, for, 690 329-331 pulsed dye laser therapy for, 693 oculocutaneous features of, 561-565 Carbohydrate metabolism, disorders of, Ciliary body melanomas, oculocutaneous features of, oculocutaneous features of, 730-733 664 810 CUMULATIVE INDEX 1992 Cilofungin, dermatologic uses of, 804 Dabska tumors, dermatopathology of, 111-112 Cirdnate vulvitis, clinical features of, 451 Dacryoadenitis, oculocutaneous features of, 751-752 Clindamydn, for vulvovaginitis, in bacterial vaginosis, Dacryocystitis, oculocutaneous features of, 752 347 Dapsone, for drug-induced ocular pemphigoid, 568 Clofazimine, and hyperpigmentation, 21 for leprosy, 85 for leprosy, 85 Darier's disease, and pruritus vulvae, 305 Clomipramine, dermatologic uses of, 644 Deep penetrating nevi, dermatopathology of, 162-165 Cockayne's syndrome, oculocutaneous features of, 584 Dermatitis, atopic, and upper eyelid dermatosis Colchicine, for Behcet's disease, 714 syndrome, 552 Coliform organisms, in ocular infections, 745 oculocutaneous features of, 536-539 Collagen, heritable disorders of. See Heritable disorders contact, and upper eyelid dermatosis syndrome, of collagen and elastic tissue. 550-551 Collagen vascular disease, and upper eyelid dermatosis dermatopathology of, giant cell lichenoid, 33 syndrome, 552 papular, in HIV infection, 61 dermatopathology of, 1-18 rheumatoid neutrophilic, 8-9 antiphospholipid syndrome, 10-12 Dermatochalasis, oculocutaneous features of, 796-798 disorders assodated with antineutrophU cyto¬ Dermatofibromas, extending into subcutaneous tissue, plasmic anhbodies, 12-15 dermatopathology of, 205-208 L-tryptophan-related eosinophilia-myalgia syn¬ vulvar, 381 drome, 1-5 with atypical cells, dermatopathology of, 203-205 rheumatoid neutrophilic dermatitis, 8-9 Dermatofibrosarcoma protuberans, dermatopathology subacute cutaneous lupus erythematosus, 5-8 of, 205, 208 Completely regressed malignant melanoma, Dermatomyofibromas, dermatopathology of, 212-215 dermatopathology of, 183-187 Dermatopathology, new developments in, acquired Condylomata acuminata, vulvar, 405—406 benign vascular lesions. See Acquired benign Congenital nevi, in neonates, dermatopathology of, vascular lesions. 170-175 adnexal neoplasms. See Adnexal neoplasms. Conjunctiva, disorders of, atopic dermatihs and, 537 benign fibrous and fibrohistiocytic tumors. See Be¬ Conjunctival granulomas, in sarcoidosis, 710 nign fibrous and fibrohistiocytic tumors. Conjunctival lesions, in AIDS, 778 collagen vascular disease. See Collagen vascular dis¬ Conjunchval melanomas, oculocutaneous features of, ease. 664 drug eruptions. See Drug eruptions. Conjunctivitis, and upper eyelid dermatosis syndrome, dysplastic nevi. See Dysplastic nevi. 552 HIV infection. See HIV infection. bacterial, 756 leprosy. See Leprosy. herpetic, 747 lymphomas. See Lymphomas. in erythema multiforme/Stevens-Johnson syndrome/ melanocytic lesions. See Melanocytic lesions. toxic epidermal necrolysis spectrum, 576, 578 neural neoplasms. See Neural neoplasms. in Lyme disease, 767 panniculitis. See Panniculitis. inclusion, 757 Dermatophyte infections, ketoconazole for, 800 staphylococcal, 742 oculocutaneous features of, 746 viral, 757-758 Dermatoses, vulvar, 297-308 Connective tissue disease, panniculitis in, 39, 41 and vulvodynia, 425-426 Contact dermahtis, and upper eyelid dermatosis atopic dermatitis, 301 syndrome, 550-551 bullous disease, 304-305 vulvar, and desquamative vulvihs, 333-334 erythema multiforme and Stevens-Johnson syn¬ and pruritus vulvae, 299-301 drome, 305 Contact urticaria, and upper eyelid dermatosis Hailey-Hailey disease, 305 syndrome, 551 pemphigoid, 305 Cornea, ultraviolet radiahon damage to, 486—487 pemphigus, 304-305 Corneal deposits, antimalarial medications and, 518 chronic dermatitis and lichen simplex chronicus, Corneal erosions, in tyrosinemia, 726 301-302 Corneal infiltrates, staphylococcal, 742 contact dermatitis, 299-301 Cosmesis, for periorbital hemangiomas, 659 Darier's disease, 305 Cowden's disease, sclerotic fibromas in, 210-211 evaluation of, 297-298 Crab louse infestation, of eyelashes, argon laser factitial dermatitis, 302-303 therapy for, 692 fixed drug eruptions, 306 Cranial nerve abnormalities, in Lyme disease, 769 Fox-Fordyce disease, 306 Crohn's disease, vulvar, 448—449 papulosquamous disease, 303-304 Cryotherapy, for HPV infection, 260 fungal disease, 304 Cushing's syndrome, oculocutaneous features of, 723 lichen planus, 304 Cutaneous eruptions of lymphocyte recovery, psoriasis, 303-304 dermatopathology of, 21-23 seborrheic dermatitis, 304 Cutaneous nerve sheath myxomas, dermatopathology plasma cell vulvitis, 305-306 of, 219-224 ulcers, 306 Cyclophosphamide, for drug-induced ocular vaginitis and, 303 pemphigoid, 568 Desipramine, dermatologic uses of, 643 Cytomegalovirus infections, in AIDS, 779-780 Desmoplastic malignant melanoma, dermatopathology in HIV infection, 65 of, 180-183 Cytophagic panniculitis, dermatopathology of, 44, 47 Desmoplastic nevi, dermatopathology of, 167-170 CUMULATIVE INDEX 1992 811 Desquamative vulvitis, 325-337 Edema, macular, in diabetes, 718 chronic bullous disease of childhood and, 331 photocoagulation for, lasers in, 695 cicatricial pemphigoid and, 329-331 Ehlers-Danlos syndrome, oculocutaneous features of, contact dermatitis and, 333-334 592-593 erythema multiforme major and, 332-333 Elastic tissue, heritable disorders of. See Heritable lichen planus and, 325, 327 disorders of collagen and elastic tissue. lichen sclerosus and, 328-329 Electrodesiccation, for HPV infection, 260-261 lupus erythematosus and, 333 Electroretinogram, principles of, 523-524 nonspecific supportive care for, 335-336 Embolization, atheromatous, and hemorrhagic pemphigus vulgaris and pemphigus vegetans and, panniculitis, 53 331-332 for periorbital hemangiomas, 659 squamous cell carcinoma in situ and, 334-335 Encephalofacial angiomatosis, oculocutaneous features Stevens-Johnson syndrome and, 332-333 of, 633-637 toxic epidermal necrolysis and, 332-333 Endocrine disorders, vulvar. See Vulva. Diabetes, oculocutaneous features of, 717-719 Endometriosis, vulvar, 374, 376 vulvar features of, 452 Endovascular papillary angioendotheliomas, Diabetic retinopathy, and macular edema, dermatopathology of, 111-112 photocoagulation for, lasers in, 695 Enucleation, for choroidal melanomas, 667 oculocutaneous features of, 718-719 Enzyme-linked immunoassay, in Lyme disease, 771- Dimethylmorpholines, dermatologic uses of, 804 772 Dixyrazine-induced ichthyosis, oculocutaneous features Eosinophilia-myalgia syndrome, L-tryptophan-related, of, 605 dermatopathology of, 1-5 Doxepin, dermatologic uses of, 643 Eosinophilic folliculitis, in HIV infection, 60-61 Doxorubicin, photosensitizing effects of, ocular, 491 Eosinophilic panniculitis, dermatopathology of, 52-53 Doxycycline, for Lyme disease, 772 Epidermal nevi, oculocutaneous features of, 587 for rosacea, 535-536 Epidermodysplasia verruciformis, in HIV infection, 65- D-Penicillamine, to prevent ultraviolet photodamage, 66 ocular, 500 Epidermolysis bullosa acquisita, oculocutaneous Drug eruptions, and pruritus vulvae, 306 features of, 559-560 histopathology of, 19-36 Epiloia, oculocutaneous features of, 615-616, 630-632 chemotherapeutic drugs, 21-27 Epithelioid cell histiocytomas, dermatopathology of, hyperpigmentation, 19-21 211-212 inflammatory, 27-34 Epithelioid hemangioendotheliomas, dermatopathology generalized pustular toxic erythema, 27-28 of, 109 giant cell lichenoid dermatitis, 33 Epithelioid hemangiomas, dermatopathology of, 108- pemphiguslike syndrome, 28-30 109 photosensitivity, 30-33 Epitheliomas, eccrine, dermatopathology of, 145-146 pseudo-mycosis fungoides syndrome, 33-34 intraepidermal, dermatopathology of, 136-138 pseudoporphyria, 30 Erosive vulvitis. See Desquamative vulvitis. pseudoscleroderma, 34 Eruptive vellus hair cysts, carbon dioxide laser therapy panniculitis, 49 for, 690 vulvar features of, 454-455 Erythema, acral, chemotherapy-induced, 23 Drug-induced pemphigoid, oculocutaneous features of, drug-induced, 27-28 565-568 necrolytic migratory, vulvar, 453-454 Drusen, giant, in tuberous sclerosis, 632 Erythema induratum, panniculitis in, 51 Dysbetalipoproteinemia, familial, oculocutaneous Erythema migrans, in Lyme disease, 763, 765 features of, 733 Erythema mulHforme, and desquamative vulvitis, 332- Dyskeratosis congenita, oculocutaneous features of, 333 585-586, 617 and pruritus vulvae, 305 Dyspareunia, vulvar diseases and, 276 Erythema multiforme/Stevens-Johnson syndrome/toxic Dysplasias, ectodermal, oculocutaneous features of, epidermal necrolysis spectrum, 571-582. See also 588-589 Stevens-johnson syndrome; Toxic epidermal necrolysis. Dysplastic nevi, dermatopathology of, 189-201 cutaneous features of, 572-573 familial dysplastic nevus syndrome, 189-194 medical treatment of, 580-581 and malignant melanoma, 192, 194 ocular features of, 576-579 sporadic dysplastic nevus syndrome, 194 surgical treatment of, 581 and maligant melanoma, 198-200 Erythema nodosum, panniculitis in, 49-51 differential diagnosis of, 194-198 Erythema nodosum leprosum, chemotherapy for, 87- 88 dermatopathology of, 85 Erythromycin, for Lyme disease, 772, 773 Eccrine epitheliomas, dermatopathology of, 145-146 Erythropoietic porphyria, oculocutaneous features of, Eccrine squamous syringometaplasia, 729 dermatopathology of, 25-27 Erythropoietic protoporphyria, oculocutaneous features Ectodermal dysplasias, oculocutaneous features of, of, 730 588-589 Estrogen deficiency, vulvar, 451-452 Ectopia lentis, in homocystinuria, 728 Estrogen replacement therapy, for vulvar estrogen in Marfan syndrome, 593 deficiency, 452 Ectropion, in lamellar ichthyosis, 598 for vulvar vestibulitis syndrome, 442 Eczema, and upper eyelid dermatosis syndrome, 552 Etoposide, and cutaneous eruptions, 23-24 812 CUMULATIVE INDEX 1992 Etretinate, and oculocutaneous diseases, 525-526 nonphotosensitive disorders, 586-589 Excimer laser therapy, for oculocutaneous diseases, 698 aplasia cutis congenita, 589 Exophthalmos, steroids and, 509 basal cell nevus syndrome, 586-587 Eyebrows, loss of, 793-796 ectodermal dysplasias, 588-589 differential diagnosis in, 793-794 epidermal nevi, 587 reconstruction for, 794-796 focal dermal hypoplasia, 587-588 cosmehc eyebrow camouflaging in, 794 pachyonychia congenita, 586 cosmetic eyelash camouflaging in, 794-795 photosensitive disorders, 583-586 permanent pigment tattooing in, 795-796 Bloom's syndrome, 583-584 Eyelashes, crab louse infestation of, argon laser Cockayne's syndrome, 584 therapy for, 692 dyskeratosis congenita, 585-586 loss of. See Eyebrows. Rothmund-Thomson syndrome, 584 Eyelid melanomas, oculocutaneous features of, 663-664 xeroderma pigmentosum, 585 Eyelids, anatomy of, 475 Genital warts. See HPV infection. Eyes, physical injuries of, 785-791 Giant cell lichenoid dermatitis, dermatopathology of, chemical burns, 785-788 33 acid, 786-787 Giant drusen, in tuberous sclerosis, 632 alkaline, 785-786 Glaucoma, intraocular pressure in, photocoagulation treatment of, 787-788 for, lasers in, 695, 698 flame and flash burns, 788-790 neurofibromatosis and, 629 traumatic injuries, 790 steroids and, 507-508 regional anesthesia in. See Regional anesthesia. Sturge-Weber syndrome and, 636-637 Glial cell lesions, in neurofibromatosis, 626-629 Globe, perforation of, regional anesthesia and, 706 Glomeruloid hemangiomas, dermatopathology of, 105- Fabry's disease, oculocutaneous features of, 735-736 106 Facial angiofibromas, in tuberous sclerosis, 630-631 Glycogenoses, oculocutaneous features of, 730-732 Familial combined hyperlipidemia, oculocutaneous Glycoprotein storage diseases, oculocutaneous features features of, 734 of, 736-737 Familial dysbetalipoproteinemia, oculocutaneous Gonorrhea, diagnosis and treatment of, 460-461 features of, 733 vulvar, 394-396 Familial dysplastic nevus syndrome, dermatopathology Gout, oculocutaneous features of, 723-724 of, 189-194 Gouty panniculitis, dermatopathology of, 51-52 Familial hypercholesterolemia, oculocutaneous features Granular cell tumors, vulvar, 383 of, 733-734 Granuloma inguinale, vulvar, 388-389 Farber's disease, oculocutaneous features of, 736 Granulomas, conjunctival, in sarcoidosis, 710 Fasciitis, necrotizing, vulvar, 447 pyogenic, dermatopathology of, 100 nodular, 381 vulvar, 378 Fenretinide, and oculocutaneous diseases, 526 Griseofulvin, photosensitizing effects of, ocular, 492 Fibroma molluscum, in neurofibromatosis, 626 Gunther's disease, oculocutaneous features of, 729 Fibromas, pleomorphic, dermatopathology of, 208-209 sclerotic, dermatopathology of, 210-211 vulvar, 380-381 Fibrous histiocytomas, vulvar, 381 Hailey-Hailey disease, and pruritus vulvae, 305 Filariasis, vulvar, 446 Hartnup's disease, oculocutaneous features of, 727 Flame burns, of eyes, 788-790 Heerfordt's syndrome, oculocutaneous features of, 711 Flash burns, of eyes, 788-790 Hemangioendotheliomas, epithelioid, Fluconazole, dermatologic uses of, 802-803 dermatopathology of, 109 Fluorescence studies, of ultraviolet-induced ocular spindle cell, dermatopathology of, 109-111 changes, 493 Hemangiomas, acquired benign, dermatopathology of. 5-Fluorouracil, and vulvar veshbulitis syndrome, 441 See Acquired benign vascular lesions. for HPV infection, 260 capillary, carbon dioxide laser therapy for, 690 for vulvar condylomata acuminata, 406 pulsed dye laser therapy for, 693 for vulvar diseases, 279 cavernous, carbon dioxide laser therapy for, 690 Fluoxetine, dermatologic uses of, 644 pulsed dye laser therapy for, 693 Focal dermal hypoplasia, oculocutaneous features of, periorbital. See Periorbital hemangiomas. 587-588 vulvar, 376 Folliculitis, eosinophilic, in HIV infection, 60-61 Hematoporphyrins, photosensitizing effects of, ocular, Foscarnet, for retinitis, in AIDS, 780 492 Fox-Fordyce disease, and pruritus vulvae, 306 Hemorrhage, intraorbital venous, regional anesthesia Fucosidosis, oculocutaneous features of, 736 and, 706 Fungal diseases, and pruritus vulvae, 304 Hemorrhagic panniculitis, atheromatous embolization Fungal infections, of skin, in HIV infection, 64-65 and, 53 Hereditary protoporphyria, oculocutaneous features of, 730 Heredopathia atactica polyneuritiformis, Galactosemia, oculocutaneous features of, 732-733 oculocutaneous features of, 601-602 Ganciclovir, for retinitis, in AIDS, 779-780 Heritable disorders of collagen and elastic tissue, Gaucher's disease, oculocutaneous features of, 735 oculocutaneous features of, 591-595 Genetic oculocutaneous diseases, 583-590 Ehlers-Danlos syndrome, 592-593 CUMULATIVE INDEX 1992 813 Marfan syndrome, 593-594 treatment of, 442 osteogenesis imperfecta, 592 and vulvodynia, 427-428 pseudoxanthoma elasticum, 591-592 carcinoma, 410 Herpes genitalis, diagnosis and treatment of, 464-465 condylomata acuminata, 405-406 vulvar, 415-422 intraepithelial neoplasia, 408-410 and vulvodynia, 428 latent and subclinical, 410-411 clinical features of, 416-418 papillomatosis, 406-408 diagnosis of, 418-419 Human immunodeficiency virus infection. See HIV differential diagnosis of, 419 infection. in pregnancy, 420-421 Human papillomavirus infection. See HPV infection. prevention of, 420 Hypercholesterolemia, familial, oculocutaneous treatment of, 419-420 features of, 733-734 Herpes simplex, oculocutaneous features of, 747-748 Hyperkeratotic disorders. See Ichtkyoses and Herpes simplex keratitis, atopic dermatitis and, 537 hyperkeratotic disorders. Herpes zoster, oculocutaneous features of, 748-750 Hyperlipidemia, familial combined, oculocutaneous Hidradenitis, neutrophilic eccrine, dermatopathology features of, 734 of, 25 type IV, oculocutaneous features of, 734-735 Hidradenomas, vulvar, 374 Hyperlipoproteinemias, oculocutaneous features of, Histiocytomas, epithelioid cell, dermatopathology of, 733 211-212 Hyperparathyroidism, oculocutaneous features of, 721- fibrous, vulvar, 381 722 palisading cutaneous fibrous, dermatopathology of, Hyperpigmentation, drug-induced, 19-21 208 in Sturge-Weber syndrome, 636 Histiocytosis, malignant, dermatopathology of, 44, 47 vulvar, 368 Histiocytosis X, vulvar, 454 Hyperplasia, angiolymphoid, with eosinophilia, HIV infection, dermatopathology of, 59-71 dermatopathology of, 108-109 bacterial skin infections, 61-64 intravascular papillary endothelial, dermatopathol¬ eosinophilic folliculitis, 60-61 ogy of, 107 fungal skin infections, 64-65 Hypersensitivity, to regional anesthesia, 707 HIV exanthem, 59-60 Hypertension, arterial, steroids and, 509 inflammatory skin disease, 59 Hyperthyroidism, oculocutaneous features of, 720-721 Kaposi's sarcoma, 66, 68 Hypertyrosinemia, type II, oculocutaneous features of, malignant lymphomas, 68-69 604-605 papular dermatitis, 61 Hypolipoproteinemias, oculocutaneous features of, 735 seborrheic dermatitis-like eruption, 60 Hypomelanosis of Ito, oculocutaneous features of, 616 vasculitis, 61 Hypoparathyroidism, oculocutaneous features of, 722 viral skin infections, 65-66, 262-263 Hypoplasia, focal dermal, oculocutaneous features of, herpes genitalis with, diagnosis and treatment of, 587-588 465 Hypothyroidism, oculocutaneous features of, 721 leprosy in, 90 risk of, sexually transmitted diseases and, 460 syphilis with, diagnosis and treatment of, 464 HLA typing, of vulvar lichen sclerosus, 310 HLA-B27, in Reiter's syndrome, 715 Ichthyoses and hyperkeratotic disorders, HMB-45 stain, of melanocytic lesions, 162 oculocutaneous features of, 597-607 Hodgkin's disease, dermatopathology of, 235-237 chondrodysplasia punctata, 602-604 Homocystinuria, oculocutaneous features of, 727-728 dixyrazine-induced ichthyosis, 605 Hordeola, staphylococcal, 742 KID syndrome, 600-601 HPV infection, current problems and future trends in, lamellar ichthyosis, 597-599 263-264 neutral lipid storage disease, 602 diagnosis and treatment of, 465-466 Refsum's disease, 601-602 in children, 262 Richner-Hanhart syndrome, 604-605 in HIV infection, 65-66, 262-263 Sjogren-Larsson syndrome, 599-600 spectrum of, 253-259 X-linked ichthyosis, 597 anogenital warts, 253-254 Immunobullous diseases, oculocutaneous features of, bowenoid papulosis, 255 555-570 cervical warts, 254 cicatricial pemphigoid, 561-565 subclinical infection, 258-259 drug-induced ocular pemphigoid, 565-568 vulvar papillomatosis, 254-255 epidermolysis bullosa acquisita, 559-560 treatment of, 253-267 lichen planus, 559 acids in, 260 linear IgA bullous disease, 560-561 cryotherapy in, 260 paraneoplastic bullous disorders, 558-559 electrodesiccation and lasers in, 260-261 pemphigus vulgaris, 556-558 5-fluorouracil in, 260 Immunoenhancing agents, for HPV infection, 261 inosine pranobex in, 261 Immunofluorescence studies, of drug-induced ocular interferons in, 261 pemphigoid, 564-565 podophyllin in, 259-260 of linear IgA bullous disease, 561 retinoids in, 261 of pemphigus vulgaris, 556-557 vulvar, 405-414 Immunotherapy, prophylactic, for leprosy, 89-90 and vulvar vestibulitis syndrome, 438-440 Incontinentia pigmenti, oculocutaneous features of, 617 814 CUMULATIVE INDEX 1992 Incontinentia pigmenti achromians, oculocutaneous Lacrimal system, anatomy of, 475-476 features of, 616 Lamellar ichthyosis, oculocutaneous features of, 597- Indirect fluorescent antibody titer, in Lyme disease, 599 771-772 Laser therapy, and vulvodynia, 429-430 Infections, bacterial, of choroid and retina, in AIDS, for HPV infection, 260-261 780 for periorbital hemangiomas, 658 ocular and periocular. See Ocular infections. for vulvar condylomata acuminata, 406 of skin, in HIV infection. See HIV infection. in dermatology, 688-694 opportunistic, ocular, steroids and, 508-509 argon lasers, 691-692 streptococcal, and upper eyelid dermatosis syn¬ carbon dioxide lasers, 688-691 drome, 552 Nd:YAG lasers, 694 vulvar, 445-447 pulsed dye lasers, 692-693 and vulvar vestibulitis syndrome, 438-440 Q-switched ruby lasers, 693-694 treatment of, 442 in ophthalmology, 694-698 and vulvodynia, 426-428 for photocoagulaHon, 694, 695, 698 Infectious diseases, and panniculitis, 53 for photodecomposiHon, 694, 698 Inflammation, ocular, steroids and, 508 for photodisrupHon, 694, 698 Inflammatory and papulosquamous diseases, for photoradiaHon, 694, 698 oculocutaneous features of, 533-547 future of, 698 atopic dermahtis, 536-539 Leg ulcers, in anHphospholipid syndrome, 11 blepharitis, 539-542 Leiomyomas, vulvar, 381, 383 lichen planus, 544-545 Lens, ocular, ultraviolet radiahon damage to, 487-488 pityriasis rubra pilaris, 545 LenHgines, vulvar, 362-363, 365 psoriasis, 542-544 LenHginosis profusa syndrome, oculocutaneous rosacea, 533-536 features of, 617 Infraorbital nerve block, of eyes and orbits, 703 LEOPARD syndrome, oculocutaneous features of, 617 Inosine pranobex, for HPV infection, 261 Leprosy, 73-96 Interferons, for HPV infection, 261 chemotherapy for, 85-88 for periorbital hemangiomas, 658-659 clofazimine, 85 for vulvar condylomata acuminata, 406 dapsone, 85 for vulvar intraepithelial neoplasia, 409-410 efficacy of, 87 for vulvar vestibulitis syndrome, 442 for reacHons, 87-88 Intracranial calcification, in Sturge-Weber syndrome, rifampin, 85-86 634-635 thioamides, 86 Intraepidermal endotheliomas, dermatopathology of, WHO mulHdrug regimen, 86-87 136-138 clinical features of, 76-79 Intraocular pressure, in glaucoma, photocoagulation borderline leprosy, 77-78 for, lasers in, 695, 698 indeterminate leprosy, 77 Intraocular tumors, photocoagulaHon for, lasers in, 695 lepromatous leprosy, 78 Intravascular papillary endothelial hyperplasia, neuriHc leprosy, 78-79 dermatopathology of, 107 tuberculoid leprosy, 77 Iris melanomas, oculocutaneous features of, 664 diagnosis and differenHal diagnosis of, 88-89 Isotretinoin, and oculocutaneous diseases, 525 eHology of, 73-74 for KID syndrome, 601 histopathology of, 80-83 Itraconazole, dermatologic uses of, 802 borderline leprosy, 81-82 histoid leprosy, 82-83 indeterminate leprosy, 81 lepromatous leprosy, 82 lucio leprosy, 82 Kaposi's sarcoma, in AIDS, 778 tuberculoid leprosy, 81 in HIV infection, 66, 68 in animals, 90-91 vulvar, 378, 380 in HIV infecHon, 90 Keratitis, herpetic, 748 pathogenesis of, 79-80 atopic dermatitis and, 537 prevenHon of, 89-90 in Lyme disease, 767-768 prognosis for, 89 staphylococcal, 742 reacHons to, 83-85 syphilitic, 758, 760 transmission and epidemiology of, 74-76 vascularizing, KID syndrome and, 600 Lesch-Nyhan syndrome, oculocutaneous features of, Keratoacanthomas, vulvar, 372 724-725 Keratoconjunctivitis, atopic dermatihs and, 538 Lice, pubic, in ocular infecHons, 750-751 epidemic, 758 vulvar, 401-402 Keratoconjunctivitis sicca, in Reiter's syndrome, 715 Lichen amyloidosis, oculocutaneous features of, 736 Keratoderma blennorrhagicum, in Reiter's syndrome, Lichen planus, oculocutaneous features of, 544-545, 714 559 Keratosis, seborrheic, vulvar, 371 vulvar, and desquamaHve vulviHs, 325, 327 Ketoconazole, dermatologic uses of, 800-802 and pruritus vulvae, 304 for vulvovaginitis, in candidiasis, 352-353 lichen sclerosus and, 316 KID syndrome, oculocutaneous features of, 600-601 Lichen sclerosus, genital, in males, 311 Kidney disease, calcifying panniculitis in, 51 vulvar, 285-286, 309-323 Kimura's disease, dermatopathology of, 109 and desquamaHve vulviHs, 328-329 CUMULATIVE INDEX 1992 815 and lichen planus, 316 Macular edema, in diabetes, 718 and morphea, 316 Magnetic resonance imaging, of ultraviolet-induced and vulvodynia, 425-426 ocular changes, 493, 496-497 etiology and pathogenesis of, 309-311 Malignant histiocytosis, dermatopathology of, 44, 47 in women, 313-315 Malignant lymphomas, in HIV infection, 68-69 in young girls, 311-313 Malignant melanoma, dermatopathology of. See risk of malignancy in, 315 Melanocylic lesions. terminology of, 317 dysplastic nevi and, 192, 194, 195-200 Lichen simplex chronicus, and pruritus vulvae, 301- Malignant Spitz nevi, dermatopathology of, 175 302 Malignant vulvar neoplasms, 287-295 Lid laxity, oculocutaneous features of, 796 798 Paget's disease, 290-291 Linear IgA bullous disease, oculocutaneous features of, squamous cell carcinoma, 291-294 560-561 verrucous carcinoma, 294-295 Lipid metabolism, disorders of, oculocutaneous vulvar intraepithelial neoplasia, 287-290 features of, 733-735 Marfan syndrome, oculocutaneous features of, 593-594 familial combined hyperlipidemia, 734 Meibomian gland dysfunction, blepharihs and, 540-542 familial dysbetalipoproteinemia, 733 Melanocytic lesions, dermatopathology of, 161-187 familial hypercholesterolemia, 733-734 balloon cell malignant melanoma, 175, 178-180 hyperlipoproteinemias, 733 completely regressed malignant melanoma, 183- type IV hyperlipidemia, 734-735 187 Lipoatrophy, panniculitis in, 41-44 congenital nevi in neonates, 170-175 Lipogranulomas, sclerosing, vulvar, 381 deep penetraHng nevi, 162-165 Lipoid proteinosis, oculocutaneous features of, 738 desmoplastic malignant melanoma, 180-183 Lipomas, vulvar, 383 desmoplastic nevi, 167-170 Lipomembranous panniculitis, dermatopathology of, 53 immunohistochemical markers, 161-162 Lisch nodules, in neurofibromatosis, 624-625 malignant Spitz nevi, 175 Livedo reticularis, in antiphospholipid syndrome, 11 pigmented spindle cell nevi, 165-167 Lobular capillary hemangiomas, dermatopathology of, in neurofibromatosis, 624-626 100 Melanocytosis, oculodermal, oculocutaneous features Lofgren's syndrome, oculocutaneous features of, 711 of, 609 L-tryptophan-related eosinophilia-myalgia syndrome, Melanomas, ocular. See Ocular melanomas. dermatopathology of, 1-5 vulvar, 367-368 Lupus erythematosus, subacute cutaneous, Melanosis, vulvar, 365-366 dermatopathology of, 5-8 Menkes' kinky-hair syndrome, oculocutaneous features vulvar, 449 of, 614 and desquamative vulvitis, 333 Merkel's cell carcinoma, dermatopathology of, 126-129 Lupus panniculitis, dermatopathology of, 37-39 Metabolic diseases, oculocutaneous features of, 717- Lyme disease, complications of, 766-767 740 laboratory diagnosis of, 771-772 adrenal diseases, 723 oculocutaneous features of, 763-775 diabetes, 717-719 acrodermatitis chronica atrophicans, 765 disorders of carbohydrate metabolism. See Carbo¬ borrelia lymphocytoma, 765 hydrate metabolism. conjunctivitis, 767 disorders of lipid metabolism. See Lipid metabolism. early, 765-766 glycoprotein storage diseases, TMt-lJ? keratitis, 767-768 hyperlipoproteinemias, 735 neuro-ophthalmologic, 768-769, 771 lipoid proteinosis, 738 ocular inflammatory syndromes, 768 lysosomal storage diseases, 735-736 pupillary abnormalities, 771 pancreatitis, 719 treatment of, 772-773 parathyroid diseases, 721-722 Lymphadenopathy, peripheral, in sarcoidosis, 712 pituitary diseases, 723 Lymphangiomas, periorbital, carbon dioxide laser protein disorders. See Protein disorders. therapy for, 690 thyroid diseases, 719-721 vulvar, 378 vulvar. See Vulva. Lymphocyte-macrophage interaction, in leprosy, 80 Metaplasia, syringosquamous, dermatopathology of, Lymphocytoma, borrelial, in Lyme disease, 765 25-27 Lymphogranuloma venereum, oculocutaneous features Metronidazole, for vulvovaginitis, in bacterial of, 757 vaginosis, 347 vulvar, 396-397 in trichomoniasis, 343-344 Lymphomas, dermatopathology of, 235-251 Microangiopathy, in AIDS, 779 Hodgkin's disease, 235-237 Microcystic adnexal carcinoma, dermatopathology of, malignant, in HIV infection, 68-69 138, 141, 143-144 mycosis fungoides and other T-cell lymphomas, Microvenular hemangiomas, dermatopathology of, 100, 44, 47, 244-248 103 non-Hodgkin's lymphomas, 237-243 Mohs micrographic surgery, for periocular sebaceous Lysosomal storage diseases, oculocutaneous features gland carcinoma, 683 of, 735-736 Molluscum contagiosum, in AIDS, 778 oculocutaneous features of, 750 vulvar, 397-399 Moraxella lacunata, in ocular infections, 744-745 Macular amyloidosis, oculocutaneous features of, 736 Morphea, vulvar, lichen sclerosus and, 316 816 CUMULATIVE INDEX 1992 Mucopolysaccharidosis, oculocutaneous features of, Neurothekeomas, dermatopathology of, 219-224 732 Neutral lipid storage disease, oculocutaneous features Multinucleate cell angiohistiocytomas, of, 602 dermatopathology of, 106-107 Neutrophilic eccrine hidradenitis, dermatopathology Multiple endocrine neoplasia syndrome, of, 25 oculocutaneous features of, 723 Nevi, choroidal, vs. choroidal melanomas, 665-666 Multiple hamartoma syndrome, sclerotic fibromas in, dysplastic. See Dysplastic nevi. 210-211 epidermal, oculocutaneous features of, 587 Multisystem disorders, oculocutaneous features of, melanocytic. See Melanocytic lesions. 709-716 vulvar, 366-367 Behqet's disease, 712-714 Nevus of Ota, argon laser therapy for, 691 Reiter's syndrome, 714-715 oculocutaneous features of, 609 sarcoidosis, 709-712 Niemann-Pick disease, oculocutaneous features of, 735 Sjogren's syndrome, 715-716 Night blindness, retinoids and, 529 Mycobacterial infections, of skin, in HIV infection, 64 vitamin A deficiency and, 524 Mycoses, vulvar, 447 Nitroimidazoles, for vulvovaginiHs, in bacterial Mycosis fungoides, dermatopathology of, 244-248 vaginosis, 347 in HIV infection, 68-69 in trichomoniasis, 343-344 vulvar, 454 Nodular fasciitis, vulvar, 381 Myopia, excimer laser therapy for, 698 Non-Hodgkin's lymphomas, dermatopathology of, Myxedema, pretibial, in hyperthyroidism, 720 237-243 Myxomas, cutaneous nerve sheath, dermatopathology Nuclear magnetic resonance imaging, of ultraviolet- of, 219-224 induced ocular changes, 493, 496-497 Nyctalopia, retinoids and, 529 vitamin A deficiency and, 524 Nystatin, for vulvovaginitis, in candidiasis, 351, 353 Nadbath-Rehman block, of eyes and orbits, 704-705 Nalidixic acid, photosensitizing effects of, ocular, 492- 493 Naproxen, and pseudoporphyria, 30 O'Brien block, of eyes and orbits, 704 Nd:YAG laser therapy, for oculocutaneous diseases, Ochronosis, oculocutaneous features of, 726-727 694, 698 Ocular anatomy, 473-482 Necrobiosis lipoidica diabeticorum, in diabetes, 718 embryology of, 476-477 Necrolytic migratory erythema, vulvar, 453-454 eyelids, 475 NecroHzing fasciiHs, vulvar, 447 globe, 473-475 Neoplasms, adnexal. See Adnexal neoplasms. extraocular muscles, 473-474 neural. See Neural neoplasms. intrinsic ocular muscles, 474-475 vulvar, 454 ocular chambers, 473 intraepithelial, 408—410 vascular supply, 475 lichen sclerosus and, 315 lacrimal system, 475-476 malignant. See Malignant vulvar neoplasms. terminology in, 477-482 Neovascularization, retinal, photocoagulation for, Ocular infections, oculocutaneous features of, 741-761 lasers in, 695 American trypanosomiasis, 751 Neural neoplasms, dermatopathology of, 219-234 canaliculitis, 752-753 cellular schwannomas, 224-226 Candida albicans in, 746 cutaneous nerve sheath myxomas, 219-224 celluliHs, 753-755 palisaded encapsulated neuromas, 229-233 chlamydial, 757-758 solitary cutaneous plexiform schwannomas, 226- coliform organisms in, 745 229 conjunctivitis, 756 Neuralgia, pudendal, and vulvodynia, 430-431 dacrycystitis, 752 Neurilemmomas, vulvar, 383 dacryoadeniHs, 751-752 Neuro-ophthalmologic abnormalities, in AIDS, 778-779 dermatophytes in, 746 in Lyme disease, 768-769, 771 herpes simplex, 747-748 Neurocutaneous syndromes, oculocutaneous features herpes zoster, 748-750 of, 623-639 molluscum contagiosum, 750 neurofibromatosis, 616-617, 623-630 Moraxella lacunata in, 744-745 glial cell lesions in, 626-629 Phthiris pubis in, 750-751 melanocytic lesions in, 624-626 phycomycosis, 755-756 Sturge-Weber syndrome, 633-637 Pityrosporum ovale in, 746-747 tuberous sclerosis, 630-632 Staphylococcus aureus in, 741-742, 744 von Hippel-Lindau disease, 632-633 Streptococcus pyogenes in, 745 Neurofibromas, vulvar, 383 syphilis, 745 Neurofibromatosis, oculocutaneous features of, 616- syphilitic keratihs, 758, 760 617, 623-630 tuberculosis, 745-746 glial cell lesions, 626-629 verruca vulgaris, 750 melanocytic lesions, 624-626 Ocular inflammatory syndromes, in Lyme disease, 768 Neurologic abnormalities, in Lyme disease, 767 Ocular melanomas, oculocutaneous features of, 663- Neuromas, palisaded encapsulated, dermatopathology 668 of, 229-233 choroidal melanomas. See Choroidal melanomas. Neurosyphilis, diagnosis and treatment of, 464 ciliary body melanomas, 664